A Cohort Study on Incidence and Factors Associated With Adverse Drug Reactions of Enalapril in Lusaka, Zambia
Pharmacology Research & Perspectives · 2026
DOI: 10.1002/prp2.70319 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pharmacology Research & Perspectives, 2026. Verfasst von Ntemena Yikon'a und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Zambia School of Medicine, Lusaka, Zambia. Hauptthemen laut MEDLINE: Enalapril, Angiotensin-Converting Enzyme Inhibitors, Angioedema, Drug-Related Side Effects and Adverse Reactions. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Science and Innovation, South Africa, NIHR Global Health Research Professorship.
Abstract (Originalsprache)
Angiotensin‐converting enzyme inhibitors (ACEIs) are widely prescribed but are associated with adverse drug reactions (ADR), including angioedema, which is typically reported in 0.1%–0.7%. Data from sub‐Saharan Africa are limited. This study aimed to estimate the incidence and risk factors of enalapril‐associated ADRs in a Zambian cohort, with particular focus on angioedema. We conducted an ambispective cohort study of 400 adults initiating enalapril at two tertiary hospitals in Lusaka, Zambia. Enalapril was the only ACEI available to the participants, and the primary outcome was the occurrence of enalapril‐associated ADRs requiring treatment discontinuation or modification. Kaplan–Meier methods were used to estimate event‐free survival, and Cox proportional hazards regression was used to identify factors associated with ADR occurrence. Angioedema occurred in 19/400 participants (4.8%). Overall, 22% (88/400) of participants experienced at least one ADR impacting treatment. The most frequent ADRs were cough (10.3%) and dizziness (5.0%). In multivariable analysis, male sex was independently associated with a lower risk of ADR (adjusted hazard ratio [aHR] 0.59, 95% CI 0.37–0.93). No significant associations were identified for the high rate of angioedema. The incidence of enalapril‐associated angioedema in this cohort was substantially higher than that reported in global as well as African American populations. These findings have clinical relevance for prescribing and monitoring ACEIs in sub‐Saharan African populations. Further studies are needed to confirm this signal and explore underlying mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Zambia School of Medicine, Lusaka, Zambia.
- Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa.
- Division of Allergy and Clinical Immunology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
ORCID-Profile: Sarah Pedretti, Helen Hoenck, Jonathan Peter, Owen Ngalamika
Förderung
- Department of Science and Innovation, South Africa
- NIHR Global Health Research Professorship
Zitieren
APA
Yikon'a, N., Mumba, N., Pedretti, S., Hoenck, H., Peter, J., & Ngalamika, O. (2026). A Cohort Study on Incidence and Factors Associated With Adverse Drug Reactions of Enalapril in Lusaka, Zambia. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70319
Vancouver
Yikon'a N, Mumba N, Pedretti S, Hoenck H, Peter J, Ngalamika O. A Cohort Study on Incidence and Factors Associated With Adverse Drug Reactions of Enalapril in Lusaka, Zambia. Pharmacology Research & Perspectives. 2026. doi:10.1002/prp2.70319
BibTeX
@article{Yikona2026,
author = {Yikon'a, Ntemena and Mumba, Ngosa and Pedretti, Sarah and Hoenck, Helen and Peter, Jonathan and Ngalamika, Owen},
title = {A Cohort Study on Incidence and Factors Associated With Adverse Drug Reactions of Enalapril in Lusaka, Zambia},
journal = {Pharmacology Research & Perspectives},
year = {2026},
doi = {10.1002/prp2.70319}
}
EUVIMED